Jump to content
Wikipedia The Free Encyclopedia

ML148

From Wikipedia, the free encyclopedia
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Pharmaceutical compound
ML148
Clinical data
Drug class 15-PGDH inhibitor
Identifiers
  • [1-(3-methylphenyl)benzimidazol-5-yl]-piperidin-1-ylmethanone
CAS Number
PubChem CID
ChemSpider
ChEBI
ChEMBL
Chemical and physical data
Formula C20H21N3O
Molar mass 319.408g·mol−1
3D model (JSmol)
  • CC1=CC(=CC=C1)N2C=NC3=C2C=CC(=C3)C(=O)N4CCCCC4
  • InChI=1S/C20H21N3O/c1-15-6-5-7-17(12-15)23-14-21-18-13-16(8-9-19(18)23)20(24)22-10-3-2-4-11-22/h5-9,12-14H,2-4,10-11H2,1H3
  • Key:YQNOQZALLOQMPY-UHFFFAOYSA-N

ML148 is a drug which acts as a reasonably potent and selective inhibitor of the enzyme 15-hydroxyprostaglandin dehydrogenase (15-PGDH), with an IC50 of 56 nM. It increases levels of prostaglandin E2 and stimulates tissue regeneration. It was one of the earliest selective 15-PGDH inhibitors developed, and is now mainly significant as a lead compound which was used to develop more potent derivatives such as HW201877, but is still used in research as its simple chemical structure and straightforward synthesis makes it a cost-effective alternative to more complex compounds.[1] [2] [3]

References

  1. Jadhav A, Niesen FH, Schultz L, Oppermann U, Maloney DJ, Simeonov A (2010). "Potent and selective inhibitors of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase (HPGD)". Probe Reports from the NIH Molecular Libraries Program. Bethesda: National Center for Biotechnology Information. PMID 21735612.
  2. Niesen FH, Schultz L, Jadhav A, Bhatia C, Guo K, Maloney DJ, et al. (November 2010). "High-affinity inhibitors of human NAD-dependent 15-hydroxyprostaglandin dehydrogenase: mechanisms of inhibition and structure-activity relationships". PLOS ONE. 5 (11) e13719. Bibcode:2010PLoSO...513719N. doi:10.1371/journal.pone.0013719 . PMC 2970562 . PMID 21072165.
  3. Duveau DY, Yasgar A, Hu X, Kouznetsova J, Brimacombe KR, Kerns EH, et al. (2010). "Discovery of two small molecule inhibitors, ML387 and ML388, of human NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase". Probe Reports from the NIH Molecular Libraries Program. Bethesda: National Center for Biotechnology Information. PMID 25834895.

AltStyle によって変換されたページ (->オリジナル) /